SCHEMBL584286

SCHEMBL584286

Oc1ccccc1C(c1ccccc1)(c1ccccc1)c1ccccc1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.52
TSHR P16473 4/20 0.52
TDP1 Q9NUW8 3/20 0.52
CA2 P00918 4/20 0.43
CA4 P22748 4/20 0.43
HPGD P15428 4/20 0.43
HSD17B10 Q99714 3/20 0.43
CA12 O43570 3/20 0.43
CA14 Q9ULX7 3/20 0.43
ALOX15 P16050 3/20 0.43
CYP3A4 P08684 2/20 0.43
KDM4E B2RXH2 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
CA3 P07451 2/20 0.43
HIF1A Q16665 2/20 0.43
NPC1 O15118 1/20 0.43
GMNN O75496 1/20 0.43
EGFR P00533 1/20 0.43
LMNA P02545 1/20 0.43
FYN P06241 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30035564 1.00 ALDH1A1 (0.52) ALDH1A1TSHRTDP1CA2CA4
SCHEMBL31205557 0.95 ALDH1A1 (0.52) ALDH1A1TSHRTDP1CA2CA4
SCHEMBL384048 0.95 ALDH1A1 (0.52) ALDH1A1TSHRTDP1CA2CA4
SCHEMBL7161191 0.95 ALDH1A1 (0.52) ALDH1A1TSHRTDP1CA2CA4
Ammonia Solution, Strong SCHEMBL31387947 0.93 ALDH1A1 (0.50) ALDH1A1TSHRTDP1CA2CA4
SCHEMBL30717192 0.93 ALDH1A1 (0.50) ALDH1A1TSHRTDP1CA2CA4
SCHEMBL8524899 0.91 ESR1 (0.52) ALDH1A1TSHRTDP1CA2CA4
SCHEMBL28141477 0.88 ALDH1A1 (0.47) ALDH1A1TSHRTDP1CA2CA4
SCHEMBL6685287 0.87 ESR1 (0.52) ALDH1A1TSHRTDP1CA2CA4
SCHEMBL23861613 0.84 TSHR (0.45) ALDH1A1TSHRTDP1CA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-5295089-A None JP disclosed
CN-112218844-B Compound, resin, composition, resist pattern forming method, circuit pattern forming method, and resin purifying method 三菱瓦斯化学株式会社 2024-04-26 CN disclosed
US-11747728-B2 Compound, resin, composition, resist pattern formation method, circuit pattern formation method and method for purifying resin MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2023-09-05 US disclosed
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-09-28 US disclosed
US-20210109448-A1 COMPOUND, RESIN, COMPOSITION, RESIST PATTERN FORMATION METHOD, CIRCUIT PATTERN FORMATION METHOD AND METHOD FOR PURIFYING RESIN MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-04-15 US disclosed
EP-3805191-A1 COMPOUND, RESIN, COMPOSITION, RESIST PATTERN FORMING METHOD, CIRCUIT PATTERN FORMING METHOD, AND RESIN PURIFICATION METHOD MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-04-14 EP disclosed
CN-112218844-A Compound, resin, composition, resist pattern forming method, circuit pattern forming method, and resin purifying method 三菱瓦斯化学株式会社 2021-01-12 CN disclosed
EP-1832613-B9 GRAFT COPOLYMER, METHOD FOR PRODUCING SAME AND RESIN COMPOSITION CONTAINING SUCH GRAFT COPOLYMER KANEKA CORP (JP) 2012-08-29 EP disclosed
EP-1832613-B1 GRAFT COPOLYMER, METHOD FOR PRODUCING SAME AND RESIN COMPOSITION CONTAINING SUCH GRAFT COPOLYMER KANEKA CORP (JP) 2012-02-15 EP disclosed
EP-1746116-B1 COPOLYMER, GRAFT COPOLYMER, GRAFT COPOLYMER PARTICLE, FLAME RETARDANT, AND RESIN COMPOSITION KANEKA CORP (JP) 2011-07-06 EP disclosed
EP-1964856-A1 POLYMER PARTICLES, PROCESS FOR PRODUCTION THEREOF, RESIN COMPOSITIONS CONTAINING THE PARTICLES, AND MOLDINGS Kaneka Corporation (JP) 2008-09-03 EP disclosed
US-20080085975-A1 Graft Copolymer, Method For Producing The Same And Resin Composition Containing The Graft Copolymer KANEKA CORPORATION (JP) 2008-04-10 US disclosed
US-20070219319-A1 Copolymer, Graft Copolymer, Graft Copolymer Particles, Flame Retardant, and Resin Composition KANEKA CORPORATION 2007-09-20 US disclosed
EP-1832613-A1 GRAFT COPOLYMER, METHOD FOR PRODUCING SAME AND RESIN COMPOSITION CONTAINING SUCH GRAFT COPOLYMER Kaneka Corporation (JP) 2007-09-12 EP disclosed
EP-1746116-A1 COPOLYMER, GRAFT COPOLYMER, GRAFT COPOLYMER PARTICLE, FLAME RETARDANT, AND RESIN COMPOSITION Kaneka Corporation (JP) 2007-01-24 EP disclosed
US-5660921-A MULTILAYER PACKAGES; TOGETHER WITH POLYIMIDE AND COPPER LAYER IBM CORPORATION (US) 1997-08-26 US disclosed
US-5593720-A Process for making a multileveled electronic package IBM CORPORATION (US) 1997-01-14 US disclosed
US-5516874-A USED BETWEEN LAYERS IN ELECTRONIC PACKAGING WITH POLYIMIDES AND COPPER IBM CORPORATION (US) 1996-05-14 US disclosed
EP-0690498-A2 Poly(arcyl ether benzimidazoles) and their use as capping layers in microelectronic structures INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1996-01-03 EP disclosed
JP-H05295089-A CURABLE RESIN COMPOSITION DAIHACHI CHEM IND CO LTD 1993-11-09 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11747728-B2 Compound, resin, composition, resist pattern formation method, circuit pattern formation method and method for purifying resin RER1, FEM1B, UNC119 ALDH1A1 3198/4885TSHR 3874/4885TDP1 4301/4885
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method RER1, NBAS, INTS9 ALDH1A1 1644/4885TSHR 2741/4885TDP1 4384/4885
US-20210109448-A1 COMPOUND, RESIN, COMPOSITION, RESIST PATTERN FORMATION METHOD, CIRCUIT PATTERN FORMATION METHOD AND METHOD FOR PURIFYING RESIN RER1, FEM1B, UNC119 ALDH1A1 3198/4885TSHR 3874/4885TDP1 4301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.